Literature DB >> 30257886

HIV-1 Nef Disrupts CD4+ T Lymphocyte Polarity, Extravasation, and Homing to Lymph Nodes via Its Nef-Associated Kinase Complex Interface.

Miguel Lamas-Murua1, Bettina Stolp1, Sheetal Kaw1, Judith Thoma2, Nikolaos Tsopoulidis1, Birthe Trautz1, Ina Ambiel1, Tatjana Reif1, Sakshi Arora1, Andrea Imle1, Nadine Tibroni1, Jingxia Wu3, Guoliang Cui3, Jens V Stein4, Motomu Tanaka2,5, Ruth Lyck4, Oliver T Fackler6.   

Abstract

HIV-1 Nef is a multifunctional protein that optimizes virus spread and promotes immune evasion of infected cells to accelerate disease progression in AIDS patients. As one of its activities, Nef reduces the motility of infected CD4+ T lymphocytes in confined space. In vivo, Nef restricts T lymphocyte homing to lymph nodes as it reduces the ability for extravasation at the diapedesis step. Effects of Nef on T lymphocyte motility are typically mediated by its ability to reduce actin remodeling. However, interference with diapedesis does not depend on residues in Nef required for inhibition of host cell actin dynamics. In search for an alternative mechanism by which Nef could alter T lymphocyte extravasation, we noted that the viral protein interferes with the polarization of primary human CD4+ T lymphocytes upon infection with HIV-1. Expression of Nef alone is sufficient to disrupt T cell polarization, and this effect is conserved among lentiviral Nef proteins. Nef acts by arresting the oscillation of CD4+ T cells between polarized and nonpolarized morphologies. Mapping studies identified the binding site for the Nef-associated kinase complex (NAKC) as critical determinant of this Nef activity and a NAKC-binding-deficient Nef variant fails to impair CD4+ T lymphocyte extravasation and homing to lymph nodes. These results thus imply the disruption of T lymphocyte polarity via its NAKC binding site as a novel mechanism by which lentiviral Nef proteins alter T lymphocyte migration in vivo.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30257886     DOI: 10.4049/jimmunol.1701420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Multifunctional Roles of the N-Terminal Region of HIV-1SF2Nef Are Mediated by Three Independent Protein Interaction Sites.

Authors:  Swetha Ananth; Katharina Morath; Birthe Trautz; Nadine Tibroni; Iart Luca Shytaj; Benedikt Obermaier; Bettina Stolp; Marina Lusic; Oliver T Fackler
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

Review 2.  In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.

Authors:  Pradeep D Uchil; Kelsey A Haugh; Ruoxi Pi; Walther Mothes
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

3.  HIV-Nef Protein Transfer to Endothelial Cells Requires Rac1 Activation and Leads to Endothelial Dysfunction Implications for Statin Treatment in HIV Patients.

Authors:  Sarvesh Chelvanambi; Samir K Gupta; Xingjuan Chen; Bradley W Ellis; Bernhard F Maier; Tyler M Colbert; Jithin Kuriakose; Pinar Zorlutuna; Paul Jolicoeur; Alexander G Obukhov; Matthias Clauss
Journal:  Circ Res       Date:  2019-08-27       Impact factor: 17.367

4.  HIV-1LAI Nef blocks the development of hematopoietic stem/progenitor cells into T lymphoid cells.

Authors:  Wei Zou; Juanjuan Xing; Fen Wang; Xinping Chen; Qian Liu; Jinyong Wang; Shijie Zou; Limin Chen; Xin Fu; Zhengping Zhou; Zhikai Wan
Journal:  AIDS       Date:  2021-05-01       Impact factor: 4.632

5.  Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells.

Authors:  Alireza Rajabzadeh; Amir Ali Hamidieh; Fatemeh Rahbarizadeh
Journal:  BMC Mol Cell Biol       Date:  2021-11-23

6.  CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.

Authors:  Lixiazi He; Christian Arnold; Judith Thoma; Christian Rohde; Maksim Kholmatov; Swati Garg; Cheng-Chih Hsiao; Linda Viol; Kaiqing Zhang; Rui Sun; Christina Schmidt; Maike Janssen; Tara MacRae; Karin Huber; Christian Thiede; Josée Hébert; Guy Sauvageau; Julia Spratte; Herbert Fluhr; Gabriela Aust; Carsten Müller-Tidow; Christof Niehrs; Gislene Pereira; Jörg Hamann; Motomu Tanaka; Judith B Zaugg; Caroline Pabst
Journal:  EMBO Mol Med       Date:  2022-03-07       Impact factor: 12.137

7.  HIV-1 infection of CD4 T cells impairs antigen-specific B cell function.

Authors:  Sheetal Kaw; Swetha Ananth; Nikolaos Tsopoulidis; Katharina Morath; Bahar M Coban; Ralph Hohenberger; Olcay C Bulut; Florian Klein; Bettina Stolp; Oliver T Fackler
Journal:  EMBO J       Date:  2020-11-04       Impact factor: 14.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.